| Literature DB >> 31201633 |
V Z Lankin1, M G Sharapov2, R G Goncharov2, A K Tikhaze3, V I Novoselov2.
Abstract
It was established that recombinant human peroxiredoxins (Prx1, Prx2, Prx4, and Prx6) inhibit natural dicarbonyls formed during free radical peroxidation of unsaturated lipids (malonic dialdehyde) and oxidative transformations of glucose (glyoxal and methylglyoxal). A possible role of the decrease in the activity of peroxiredoxins under oxidative and carbonyl stress is discussed as an important factor that triggers the molecular mechanisms of vascular wall damage in atherosclerosis and diabetes mellitus.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31201633 DOI: 10.1134/S1607672919020157
Source DB: PubMed Journal: Dokl Biochem Biophys ISSN: 1607-6729 Impact factor: 0.788